Zhang Dongjian, Gao Meng, Jin Qiaomei, Ni Yicheng, Zhang Jian
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210028, China.
Laboratories of Translational Medicine, Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing 210028, China.
Acta Pharm Sin B. 2019 May;9(3):455-468. doi: 10.1016/j.apsb.2019.02.002. Epub 2019 Feb 13.
Cell death plays important roles in living organisms and is a hallmark of numerous disorders such as cardiovascular diseases, sepsis and acute pancreatitis. Moreover, cell death also plays a pivotal role in the treatment of certain diseases, for example, cancer. Noninvasive visualization of cell death contributes to gained insight into diseases, development of individualized treatment plans, evaluation of treatment responses, and prediction of patient prognosis. On the other hand, cell death can also be targeted for the treatment of diseases. Although there are many ways for a cell to die, only apoptosis and necrosis have been extensively studied in terms of cell death related theranostics. This review mainly focuses on molecular imaging and therapeutic strategies directed against necrosis. Necrosis shares common morphological characteristics including the rupture of cell membrane integrity and release of cellular contents, which provide potential biomarkers for visualization of necrosis and necrosis targeted therapy. In the present review, we summarize the updated joint efforts to develop molecular imaging probes and therapeutic strategies targeting the biomarkers exposed by necrotic cells. Moreover, we also discuss the challenges in developing necrosis imaging probes and propose several biomarkers of necrosis that deserve to be explored in future imaging and therapy research.
细胞死亡在生物体中发挥着重要作用,是许多疾病(如心血管疾病、败血症和急性胰腺炎)的一个标志。此外,细胞死亡在某些疾病(如癌症)的治疗中也起着关键作用。细胞死亡的无创可视化有助于深入了解疾病、制定个性化治疗方案、评估治疗反应以及预测患者预后。另一方面,细胞死亡也可作为疾病治疗的靶点。虽然细胞死亡的方式有很多种,但就细胞死亡相关的诊疗而言,只有凋亡和坏死得到了广泛研究。本综述主要关注针对坏死的分子成像和治疗策略。坏死具有共同的形态学特征,包括细胞膜完整性的破坏和细胞内容物的释放,这为坏死的可视化和坏死靶向治疗提供了潜在的生物标志物。在本综述中,我们总结了为开发针对坏死细胞暴露的生物标志物的分子成像探针和治疗策略而进行的最新联合努力。此外,我们还讨论了开发坏死成像探针所面临的挑战,并提出了几种坏死生物标志物,值得在未来的成像和治疗研究中进行探索。
Acta Pharm Sin B. 2019-5
J Drug Target. 2020-7
Bioconjug Chem. 2012-9-26
Mol Imaging Biol. 2021-6
Mol Imaging Biol. 2022-8
Med Res Rev. 2018-3-12
J Drug Target. 2020-11
J Transl Med. 2025-6-12
Front Cell Dev Biol. 2021-2-22
Mol Imaging Biol. 2021-6
EJNMMI Radiopharm Chem. 2020-11-17
Sens Actuators B Chem. 2008-2-22
Crit Rev Oncog. 2018
Contrast Media Mol Imaging. 2018-4-22
Contrast Media Mol Imaging. 2018-2-26
Eur J Pharmacol. 2018-3-6
Expert Opin Ther Targets. 2018-2-15
Iran J Basic Med Sci. 2018-1
JACC Cardiovasc Imaging. 2017-12-13